From the in vitro results, olaparib could contribute to suppression of tumor invasion, and the different olaparib effects on E-cadherin in the SAS cell line would be the possible clue to the pivotal role of PARP1 activity in EMT. This evidence concerns the gene CDH1 and neoplasm.